Saturday 17 October 2026
Export DCTH’s income statement to Excel — free account
Delcath Systems, Inc.
DCTH Healthcare Medical Devices
Delcath Systems, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $85.2 million, up 129.1% from fiscal 2024. In the quarter to June 2026, revenue grew 20.6%, EPS fell 12.5% and free cash flow fell 24.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
14.08
0.73
−4.93%
Follow DCTH
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 126.25 |
Piotroski F-Score |
3 | — | — | 3 | 4 | 5 | 3 | 3 | 6 | 7 |
Altman Z-Score |
8,784.82 | — | (84.80) | (41.34) | (14.71) | (17.65) | (41.06) | (19.11) | 17.55 | 13.26 |
P/S ratio |
256,215.11 | 0.00 | 2.20 | 0.35 | 31.55 | 15.58 | 11.28 | 32.30 | 9.23 | 4.24 |
Altman Z″-Score (non-manufacturers) |
(29.37) | (132.97) | (202.52) | (96.44) | (35.27) | (40.83) | (95.97) | (45.05) | (8.72) | 1.26 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17.25 |
Beneish M-Score |
(3.14) | (18.12) | (5.44) | 1.12 | (0.37) | (3.07) | 2.87 | (5.01) | 16.41 | (2.73) |
P/Operating CF |
(141,145.05) | 0.00 | (4.07) | (0.10) | (10.30) | (9.19) | (4.17) | (8.16) | (341.23) | 43.86 |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 2.35 | 4.63 | 0.00 | 4.23 | 4.99 | 3.25 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 2.35 | 4.63 | 0.00 | 4.23 | 4.99 | 3.25 |
EV/Sales |
256,202.42 | 0.40 | 1.18 | (4.83) | 14.35 | 12.22 | 9.82 | 17.53 | 7.85 | 3.20 |
EV/EBITDA |
0.00 | 0.30 | 0.00 | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(35,907.64) | (0.07) | (0.27) | 0.32 | (1.03) | (1.92) | (1.07) | (1.16) | (15.63) | 12.11 |
EV/FCF |
(35,267.45) | (0.07) | (0.27) | 0.32 | (1.00) | (1.91) | (1.06) | (1.16) | (15.18) | 13.01 |
Quick Ratio |
0.89 | 0.72 | 0.23 | 0.64 | 2.87 | 4.53 | 0.83 | 1.99 | 10.44 | 9.39 |
Current Ratio |
0.95 | 0.97 | 0.33 | 0.79 | 3.22 | 5.23 | 1.10 | 2.26 | 12.01 | 10.92 |
Net Debt/EBITDA |
16.98 | (1.44) | 0.15 | 0.54 | 1.34 | 0.50 | 0.12 | 0.87 | 4.33 | 132.51 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 14.07% | 1.30% | 45.32% | 43.90% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | (0.31) | 0.02 | 1.26 | (1.34) | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.08 | 0.12 | 0.43 | 0.15 | 0.07 | 0.10 | 0.11 | 0.07 | 0.65 | 0.85 |
Operating CF/Net income |
0.79 | 0.34 | 0.77 | 2.67 | 0.94 | 0.88 | 0.68 | 0.66 | 0.71 | 8.34 |
Capex/Depreciation |
(0.02) | (0.02) | (0.02) | (0.01) | (4.68) | (0.30) | (0.23) | (0.06) | (5.48) | 1.15 |
Interest Coverage |
(1.15) | (0.84) | (3.40) | (4.19) | (121.73) | (20.68) | (12.61) | (26.53) | 99.28 | (0.23) |
| (505.44%) | 11,242.36% | 269.57% | 83.39% | (308.01%) | (150.74%) | (1,198.36%) | (961.44%) | (62.44%) | 3.00% | |
| (70.51%) | (206.88%) | (244.38%) | (84.34%) | (99.13%) | (75.71%) | (143.21%) | (168.85%) | (45.81%) | 2.70% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (153,318.75%) | 0.00% | 0.00% | (50.00%) | 2.04% |
Return on Tangible Assets |
2,099.42% | (4,253.87%) | 176.25% | 336.07% | (102.35%) | (96.62%) | (1,284.59%) | (216.11%) | (38.02%) | 2.42% |
Average Days of Receivables |
73.84 | 42.62 | 62.67 | 4.85 | 12.64 | 4.52 | 49.13 | 42.60 | 106.84 | 50.29 |
Research and Development Expense of Revenue |
424.10% | 386.56% | 576.75% | 600.63% | 680.50% | 387.57% | 683.45% | 847.55% | 37.29% | 34.31% |
Selling, General and Administrative Expense of Revenue |
473.59% | 356.69% | 288.20% | 713.86% | 674.85% | 383.60% | 636.37% | 1,070.70% | 79.43% | 51.07% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
21.44% | 4.75% | 1.70% | 17.53% | 237.61% | 220.31% | 292.06% | 394.72% | 26.25% | 28.43% |
Graham Net Nets |
0.00 | 0.00 | (2.12) | (14.45) | 0.38 | 0.18 | (0.25) | 0.21 | 0.19 | 0.30 |
Graham Number |
1,905,206.61 | 0.00 | 2,104.70 | 1,380.15 | 0.00 | 0.00 | 7.67 | 0.00 | 0.00 | 2.36 |
Earnings Yield |
(488.77%) | (4,355.86%) | (256.85%) | (1,623.16%) | (623.55%) | (46.84%) | (114.45%) | (72.26%) | (8.14%) | 0.79% |
Free Cash Flow Yield |
0.00% | 0.00% | (197.78%) | (4,308.52%) | (45.54%) | (41.07%) | (82.02%) | (46.94%) | (5.60%) | 5.80% |
Revenue per Share |
415.00 | 0.00 | 89.19 | 61.00 | 0.57 | 0.50 | 0.31 | 0.13 | 1.30 | 2.38 |
Operating CF per Share |
(2,961.04) | 0.00 | (385.65) | (914.63) | (7.89) | (3.16) | (2.81) | (1.93) | (0.66) | 0.63 |
Capex per Share |
(53.75) | 0.00 | (1.99) | (0.93) | (0.27) | (0.02) | (0.02) | 0.00 | (0.02) | (0.04) |
Free Cash Flow per Share |
(3,014.79) | 0.00 | (387.64) | (915.56) | (8.16) | (3.18) | (2.84) | (1.93) | (0.67) | 0.59 |
Cash per Share |
6,603.33 | 0.00 | 93.66 | 393.17 | 9.92 | 3.77 | 1.33 | 2.00 | 1.87 | 2.54 |
Shareholders Equity per Share |
(310.42) | 0.00 | (391.07) | (245.44) | 7.62 | 1.67 | (0.66) | 0.97 | 2.41 | 3.10 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(310.42) | 0.00 | (391.07) | (245.44) | 7.62 | 1.67 | (0.66) | 0.97 | 2.41 | 3.10 |
Free Cash Flow |
(14.47) | (15.92) | (14.81) | (23.71) | (23.65) | (22.75) | (25.16) | (31.31) | (19.24) | 20.97 |
Working Capital |
(1.94) | (0.22) | (11.83) | (3.38) | 22.30 | 25.20 | 1.42 | 20.71 | 67.62 | 108.58 |
Capital Expenditures |
(0.26) | (0.52) | (0.08) | (0.02) | (0.78) | (0.14) | (0.21) | (0.06) | (0.56) | (1.55) |
Net Current Asset Value |
(2.57) | (0.62) | (15.86) | (7.95) | 19.78 | 9.98 | (7.57) | 14.32 | 65.92 | 107.12 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.38 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 413.27 |
Capex to Sales |
0.13 | 0.19 | 0.02 | 0.02 | 0.48 | 0.04 | 0.08 | 0.03 | 0.02 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 548.17 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
13.46 | 16.84 | 3.54 | 6.42 | 0.12 | 0.35 | 0.63 | 0.76 | 0.06 | (0.43) |
Cash ROIC |
(47.91%) | (265.28%) | 130.34% | (407.02%) | (46.12%) | (42.19%) | (182.25%) | (64.85%) | (15.77%) | 10.37% |
Accounts Receivable Turnover |
5.86 | 7.54 | 7.55 | 5.21 | 42.21 | 70.40 | 13.26 | 6.80 | 6.68 | 7.53 |
Accounts Payable Turnover |
1.25 | 0.32 | 0.17 | 0.12 | 0.20 | 0.56 | 0.52 | 0.42 | 6.27 | 6.52 |
Inventory Turnover |
0.78 | 0.73 | 0.96 | 0.95 | 0.85 | 0.59 | 0.40 | 0.24 | 1.21 | 1.37 |
Average Days of Payables |
394.20 | 2,002.55 | 2,790.86 | 2,301.18 | 1,011.73 | 347.05 | 1,073.72 | 581.70 | 56.68 | 82.24 |
Days of Inventory on Hand |
438.00 | 649.81 | 310.38 | 332.00 | 487.62 | 768.08 | 1,063.08 | 1,909.50 | 408.94 | 317.20 |
Average Receivables |
0.34 | 0.36 | 0.45 | 0.30 | 0.04 | 0.05 | 0.21 | 0.30 | 5.57 | 11.32 |
Average Payables |
0.44 | 2.22 | 5.78 | 6.12 | 3.15 | 1.21 | 1.33 | 1.52 | 0.99 | 1.81 |
Average Inventory |
0.71 | 0.95 | 1.05 | 0.76 | 0.75 | 1.13 | 1.71 | 2.66 | 5.13 | 8.59 |
Average Assets |
25.49 | 22.06 | 7.87 | 10.53 | 24.42 | 33.88 | 25.49 | 28.24 | 57.60 | 100.11 |
Average Common Equity |
3.56 | (0.41) | (7.13) | (10.65) | 7.86 | 17.02 | 3.05 | 4.96 | 42.26 | 89.98 |
Columns are period end dates